<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39377242</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-9987</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy</Title><ISOAbbreviation>Ther Apher Dial</ISOAbbreviation></Journal><ArticleTitle>Performance of CO-RADS in the diagnosis of COVID-19 in hemodialysis patients.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/1744-9987.14215</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Different data systems have been used to reach a common decision in the interpretation of chest computed tomography (CT) scans for the detection of COVID-19 infection. The aim of our study was to determine the usefulness of the COVID-19 Reporting and Data System (CO-RADS) for COVID-19 in patients undergoing hemodialysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included 90 hemodialysis patients who underwent chest CT and had samples available for real-time reverse transcription-polymerase chain reaction (RT-PCR). The files of the patients were retrospectively reviewed and the data were recorded. Image interpretation and CO-RADS staging were performed retrospectively by two radiologists experienced in COVID-19 patients, blinded to the RT-PCR results. The RT-PCR results were then compared with the CO-RADS stages obtained. The success of CO-RADS in diagnosing COVID-19 was evaluated according to its prediction of a positive RT-PCR result. At the same time, the relationship between CO-RADS stages and prognosis was also evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients were divided into two groups according to the RT-PCR results, of which 38 (42.2%) had positive results. Validity tests of CO-RADS were performed according to the RT-PCR test. While 71.1% of patients with CO-RADS ≥4 were RT-PCR (+), 13.2% of patients with CO-RADS ≤2 were RT-PCR (+) (p &lt; 0.001). CO-RADS ≥4 detected COVID-19 with 71.1% sensitivity and 51.9% specificity. ROC analysis confirmed the diagnostic performance of CO-RADS for predicting RT-PCR positivity with AUC = 0.73 (95% CI: 0.63-0.84). The relationship between CO-RADS stages and mortality was not significant (p = 0.21).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">CO-RADS is moderately sensitive and poorly specific for the diagnosis of COVID-19 in hemodialysis patients. In these patients, CO-RADS would be more useful to exclude other infections than to diagnose COVID-19.</AbstractText><CopyrightInformation>© 2024 International Society for Apheresis and Japanese Society for Apheresis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ozkan Kurtgoz</LastName><ForeName>Pervin</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4206-0525</Identifier><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sackan</LastName><ForeName>Fatih</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0257-8917</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buyukterzi</LastName><ForeName>Meral</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2486-0956</Identifier><AffiliationInfo><Affiliation>Department of Radiology, University of Health Sciences, Konya City Hospital, Konya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guney</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-1646-2811</Identifier><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Ther Apher Dial</MedlineTA><NlmUniqueID>101181252</NlmUniqueID><ISSNLinking>1744-9979</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">CO‐RADS</Keyword><Keyword MajorTopicYN="N">hemodialysis</Keyword><Keyword MajorTopicYN="N">performance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39377242</ArticleId><ArticleId IdType="doi">10.1111/1744-9987.14215</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the mystery surrounding post‐acute sequelae of COVID‐19. Front Immunol. 2021;12:686029.</Citation></Reference><Reference><Citation>Chotpitayasunondh T, Fischer TK, Heraud JM, Hurt AC, Monto AS, Osterhaus A, et al. Influenza and COVID‐19: what does co‐existence mean? Influenza Other Respi Viruses. 2021;15(3):407–412.</Citation></Reference><Reference><Citation>Rincón A, Moreso F, López‐Herradón A, Fernández‐Robres MA, Cidraque I, Nin J, et al. The keys to control a COVID‐19 outbreak in a haemodialysis unit. Clin Kidney J. 2020;13:542–549.</Citation></Reference><Reference><Citation>Tang H, Tian JB, Dong JW, Tang XT, Yan ZY, Zhao YY, et al. Serologic detection of SARS‐CoV‐2 infections in hemodialysis centers: a multicenter retrospective study in Wuhan, China. Am J Kidney Dis. 2020;76:490–499.</Citation></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID‐19‐related death using OpenSAFELY. Nature. 2020;584:430–436.</Citation></Reference><Reference><Citation>Semenzato L, Botton J, Drouin J, Cuenot F, Dray‐Spira R, Weill A, et al. Chronic diseases, health conditions and risk of COVID‐19‐related hospitalization and in‐hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health Eur. 2021;8:100158.</Citation></Reference><Reference><Citation>De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye MM, De Vriese AS, et al. Incidence, characteristics, and outcome of COVID‐19 in adults on kidney replacement therapy: a regionwide registry study. J Am Soc Nephrol. 2021;32:385–396.</Citation></Reference><Reference><Citation>Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, et al. COVID‐19‐related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020;35:1973–1983.</Citation></Reference><Reference><Citation>Jager KJ, Kramer A, Chesnaye NC, Couchoud C, Sánchez‐Álvarez JE, Garneata L, et al. Results from the ERA‐EDTA Registry indicate a high mortality due to COVID‐19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020;98:1540–1548.</Citation></Reference><Reference><Citation>Abbasi‐Oshaghi E, Mirzaei F, Farahani F, Khodadadi I, Tayebinia H. Diagnosis and treatment of coronavirus disease 2019 (COVID‐19): laboratory, PCR, and chest CT imaging findings. Int J Surg. 2020;79:143–153.</Citation></Reference><Reference><Citation>Garg M, Prabhakar N, Bhalla AS, Irodi A, Sehgal I, Debi U, et al. Computed tomography chest in COVID‐19: when &amp; why? Indian J Med Res. 2021;153(1 &amp; 2):86–92.</Citation></Reference><Reference><Citation>Inui S, Kurokawa R, Nakai Y, Watanabe Y, Kurokawa M, Sakurai K, et al. Comparison of chest CT grading Systems in Coronavirus Disease 2019 (COVID‐19) pneumonia. Radiol Cardiothorac Imaging. 2020;2(6):e200492.</Citation></Reference><Reference><Citation>World Health Organization. Global surveillance for COVID‐19 disease caused by human infection with novel coronavirus (COVID‐19): interim guidance, 27 February 2020. World Health Organization. 2020.</Citation></Reference><Reference><Citation>Prokop M, van Everdingen W, van Rees Vellinga T, van Ufford HQ, Stöger L, Beenen L, et al. CO‐RADS: a categorical CT assessment scheme for patients suspected of having COVID‐19‐definition and evaluation. Radiology. 2020;296(2):97–104.</Citation></Reference><Reference><Citation>Penha D, Pinto EG, Matos F, Hochhegger B, Monaghan C, Taborda‐Barata L, et al. CO‐RADS: Coronavirus classification review. J Clin Imaging Sci. 2021;11:9.</Citation></Reference><Reference><Citation>Islam N, Ebrahimzadeh S, Salameh JP, Kazi S, Fabiano N, Treanor L, et al. Thoracic imaging tests for the diagnosis of COVID‐19. Cochrane Database Syst Rev. 2021;3:CD013639.</Citation></Reference><Reference><Citation>Martinez‐Fierro ML, González‐Fuentes C, Cid‐Guerrero D, González Delgado S, Carrillo‐Martínez S, Gutierrez‐Vela EF, et al. Radiological findings increased the successful of COVID‐19 diagnosis in hospitalized patients suspected of respiratory viral infection but with a negative first SARS‐CoV‐2 RT‐PCR result. Diagnostics. 2022;12(3):687.</Citation></Reference><Reference><Citation>Vicini S, Panvini N, Bellini D, Rengo M, Ciotola M, de Vivo M, et al. Radiographers and COVID‐19 pneumonia: diagnostic performance using CO‐RADS. Radiography. 2021;27(4):1078–1084.</Citation></Reference><Reference><Citation>De Smet K, De Smet D, Ryckaert T, Laridon E, Heremans B, Vandenbulcke R, et al. Diagnostic performance of chest CT for SARS‐CoV‐2 infection in individuals with or without COVID‐19 symptoms. Radiology. 2021;298(1):30–37.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>